Jumawid, Essyll Briallyn C.

HRN: 23-79-57  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/07/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/07/2025
08/14/2025
IV
250mg
Q6hours
PCAP-C
Checking Initial Appropriateness 
08/07/2025
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
08/07/2025
08/11/2025
ORAL
2.5ml
Once A Day
PCAP-C
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: